Literature DB >> 7591220

Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22.

C Moog-Lutz1, P Bouillet, C H Régnier, C Tomasetto, M G Mattei, M P Chenard, P Anglard, M C Rio, P Basset.   

Abstract

Using differential screening of a breast cancer cDNA library, we isolated a cDNA encoding the psoriasin (S100A7) protein, previously identified in psoriatic epidermis. In the present study, we demonstrate that the psoriasin gene is expressed in breast cancer cell lines and in cancer cells of some breast carcinomas but not in any non-cancerous tissues examined, except skin. Another S100 gene, S100C, which we co-localized with the psoriasin gene to human chromosome 1q21-q22, was found to be expressed in most tissues and cell lines evaluated. These findings add support to the concept that the S100 genes clustered in human chromosome 1q21-q22 are individually controlled and that some of them may be involved in the regulation of cell transformation and/or differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591220     DOI: 10.1002/ijc.2910630225

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  CacyBP/SIP expression is involved in the clinical progression of breast cancer.

Authors:  Ningju Wang; Qingyong Ma; Yinna Wang; Gang Ma; Huihong Zhai
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Depicting the spatial distribution of proteins in human tumor tissue combining SELDI and MALDI imaging and immunohistochemistry.

Authors:  Liane Wehder; Günther Ernst; Anna C Crecelius; Orlando Guntinas-Lichius; Christian Melle; Ulrich S Schubert; Ferdinand von Eggeling
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

3.  Psoriasin (S100A7) expression and invasive breast cancer.

Authors:  S Al-Haddad; Z Zhang; E Leygue; L Snell; A Huang; Y Niu; T Hiller-Hitchcock; K Hole; L C Murphy; P H Watson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.

Authors:  Yadwinder S Deol; Mohd W Nasser; Lianbo Yu; Xianghong Zou; Ramesh K Ganju
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

5.  MALDI-imaging segmentation is a powerful tool for spatial functional proteomic analysis of human larynx carcinoma.

Authors:  Theodore Alexandrov; Michael Becker; Orlando Guntinas-Lichius; Günther Ernst; Ferdinand von Eggeling
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-06       Impact factor: 4.553

6.  Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library.

Authors:  I Marenholz; M Zirra; D F Fischer; C Backendorf; A Ziegler; D Mischke
Journal:  Genome Res       Date:  2001-03       Impact factor: 9.043

7.  Placental transcriptomes in the common aneuploidies reveal critical regions on the trisomic chromosomes and genome-wide effects.

Authors:  Katherine Bianco; Matthew Gormley; Jason Farrell; Yan Zhou; Oliver Oliverio; Hannah Tilden; Michael McMaster; Susan J Fisher
Journal:  Prenat Diagn       Date:  2016-07-25       Impact factor: 3.050

8.  Relationship between mammaglobin expression and estrogen receptor status in breast tumors.

Authors:  Xiao-feng Guan; Mohammad K Hamedani; Adewale Adeyinka; Christina Walker; Angela Kemp; Leigh C Murphy; Peter H Watson; Etienne Leygue
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

9.  Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.

Authors:  Amita Sneh; Yadwinder S Deol; Akaansha Ganju; Konstantin Shilo; Thomas J Rosol; Mohd W Nasser; Ramesh K Ganju
Journal:  Breast Cancer Res Treat       Date:  2013-03-28       Impact factor: 4.872

10.  Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells.

Authors:  Barbara C Spink; James A Bennett; Brian T Pentecost; Nicole Lostritto; Neal A Englert; Geoffrey K Benn; Angela K Goodenough; Robert J Turesky; David C Spink
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-18       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.